The goal of this study was to determine whether pancreatic cancer cells retain their viability and tumorigenic capacity independent of KRAS, to identify stages of tumor progression when KRAS is essential, and to explore changes that enable cancer cells to escape from KRAS dependence. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.